Q&A With Rudolph Tanzi, from Massachusetts General: Finding Therapies for Alzheimer's Disease No Easy Task

Video

While understanding alzheimer's disease has improved over the past year, finding therapies for the condition has taken longer but is now moving forward.

While understanding alzheimer's disease has improved over the past year, finding therapies for the condition has taken longer but is now moving forward.

Rudolph Tanzi, PhD, from Massachusetts General Hospital and Harvard Medical School discussed the current status of treatments for the condition and how more progress can now be made in the field. Tanzi said that the understanding of the condition had only become "lucid in the past year or so." Because of that he said prior tests and attempts at treatments have not been able to reach their desired goals. "In many respects the amyloid hypothesis didn't fail the trials, the trials faild the hypothesis.

Related Videos
Reviewing 2023 with FDA Commissioner Robert M. Califf, MD
A Year of RSV Highs and Lows, with Tina Tan, MD
Gestational Low-Dose Aspirin Does Not Increase Risk of IBD Flares in Women
Riha Bhatt, MD: Mimickers and Concurrent Diseases in Pediatric IBD
Elizabeth Spencer, MD: Precision Medicine in Pediatric IBD
Anita Clayton, MD: Zuranolone for Postpartum Depression
Mikkael Sekeres, MD:
Lynn Malec, MD: FVIII Therapy Improves Levels in Pediatric Patients with Hemophilia A
Lynn Malec, MD:
© 2024 MJH Life Sciences

All rights reserved.